CRNX CRINETICS PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2023 - Underwriting Agreement Crinetics Pharmaceuticals, Inc. entered into an underwriting agreement for the issuance and sale of 11,441,648 shares of common stock, expected to raise approximately $328.6 million.Get access to all SEC 8-K filings of the CRINETICS PHARMACEUTICALS INC